Imatinib-mesylate - Globe Thesis

Keyword [Imatinib-mesylate] Result: 21 - 40 \| Page: 2 of 5
21.	The Study Of Imatinib Mesylate On Radiosensitivity Of Human Cervical Cancer Cell Line Hela Under Normal And Hypoxia Growth Conditions
22.	Treatment And Prognosis Of Gastrointestinal Stromal Tumor: An Analysis Of 144 Patients
23.	Further Studies On The Side Effects Of Imatinib In The Treatment Of Patients With GIST
24.	Analysis The Molecular Reaction And Resistance Mechanism Of Imatinib Mesylate Within 137 CML Patients
25.	The Study Of MicroRNA-218about Its Role And Mechanism In Gastrointestinal Stormal Tumor Cells
26.	The Prediction Of Early Response And The Role Of CFL1 In The Treatment Of Chronic Myeloid Leukemia
27.	The Analaysis Of Therapeutic Effects Of Imatinib Mesylate On102Patients With Chronic Myloid Leukemia
28.	The Study Of Current Situation Of Imatinib Therapy In Gastrointestinal Stromal Tumor Patients
29.	HOCT1、ABCB1Gene Expression And ABCB1Single Nucleotide Polymorphism Are Correlated With The Efficacy Of Imatinib Mesylate Treatment In Chronic Myelocytic Leukemia
30.	Preliminary Research On PR1Specific Cytotoxic T Lymphocytes Of Chronic Myeloid Leukemia Patients Accepted Different Treatment
31.	C-Abl’s Roles In Mouse Gastrointestinal Homeostasis
32.	Detection Of Cytogenetic And Molecular Biology In Chronic Myeloid Leukemia Patients
33.	The Clinical Observation Of73Cases Of Gastrointestinal Stromal Tumors Treated With Imatinib
34.	Functional Role Of MiR-21in Regulating Apoptosis Resistance Of CML CD34+stem/progenitor Cells To Imatinib Mesylate And Its Related Mechanism
35.	The Relationgship Between Adherence And Clinical Of Imatinib Therapy In Gastrointestinal Stromal Tumor
36.	Imatinib Mesylate For Chronic-Phase Chronic Myeloid Leukemia:Initial Treatment Versus After Failure Of IFN-α
37.	Gastrointestinal Stromal Tumor Postoperative Adjuvant Reatment Of Imatinib Mesylate And Influencing Factors Of Esearch(Analysis Of 120 Cases GIST)
38.	Study On Effect Of Imatinib Mesylate On The Growth And Apoptosis Of Cisplatin-resistant Human Ovarian Cancer Cell Line SKOV3/DDP
39.	Studies On Quality Standard Of Imatinib Mesylate And Imatinib Mesylate Tablets
40.	Clinical Research In 50 Patients With Chronic Myeloid Leukemia Treated With Imatinib Mesylate
<<First <Prev Next> Last>> Jump to